Position in ICLR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,084
+$757 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#393
of 421 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CALDWELL SUTTER CAPITAL, INC. holds $712,468 across 8 Diagnostics & Research names. ICLR ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,897 | $551,820 | |
| 2 | A |
Agilent Technologies, Inc.
|
590 | $78,369 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
83 | $41,612 | |
| 4 | GRAL |
GRAIL, Inc.
|
518 | $35,363 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
12 | $2,318 | |
| 6 | ICLR |
Icon PLC
This page
|
12 | $2,084 | |
| 7 | ILMN |
Illumina, Inc.
|
3 | $527 | |
| 8 | WAT |
Waters Corp /De/
|
1 | $375 |
All Filings in ICLR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,084 | 12 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,327 | 12 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,186 | 12 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,100 | 12 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,745 | 12 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,099 | 12 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,516 | 12 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,447 | 12 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,761 | 12 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $4,031 | 12 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,396 | 12 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,955 | 12 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $3,002 | 12 | Shares | Sole | 2023-07-19 | |
| No filing history on record for this holder in this stock. | ||||||